ALS/FTD‐associated FUS activates GSK‐3β to disrupt the VAPB–PTPIP51 interaction and ER–mitochondria associations

Stoica, R., Paillusson, S., Gomez‐Suaga, P. et al. (10 more authors) (2016) ALS/FTD‐associated FUS activates GSK‐3β to disrupt the VAPB–PTPIP51 interaction and ER–mitochondria associations. EMBO Reports. e201541726. ISSN 1469-3178

Abstract

Metadata

Authors/Creators:
  • Stoica, R.
  • Paillusson, S.
  • Gomez‐Suaga, P.
  • Mitchell, J.C.
  • Lau, D.H.W.
  • Gray, E.H.
  • Sancho, R.M.
  • Vizcay‐Barrena, G.
  • De Vos, K.J. ORCID logo https://orcid.org/0000-0003-2161-6309
  • Shaw, C.E.
  • Hanger, D.P.
  • Noble, W.
  • Miller, C.C.J.
Copyright, Publisher and Additional Information: © 2016 The Authors. This is an open access article under the terms of the Creative Commons Attribution 4.0 License (https://creativecommons.org/licenses/by/4.0/), which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
Dates:
  • Accepted: 13 June 2016
  • Published (online): 14 July 2016
  • 14 July 2016
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > Department of Neuroscience (Sheffield)
The University of Sheffield > Sheffield Teaching Hospitals
Depositing User: Symplectic Sheffield
Date Deposited: 18 Jul 2016 13:39
Last Modified: 13 Jan 2020 10:38
Published Version: http://dx.doi.org/10.15252/embr.201541726
Status: Published
Publisher: EMBO Press
Refereed: Yes
Identification Number: https://doi.org/10.15252/embr.201541726

Export

Statistics